JENNIFER ROSE: Open Payments
NPI 1720754674 · MUSCLE SHOALS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$233 in 13 payments from 8 companies in 2025. Trend: 2023 $455 · 2024 $2,192 · 2025 $233
Food & beverage: $233
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $50 |
| Lilly USA, LLC | 2 | $37 |
| ABBVIE INC. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Exact Sciences Corporation | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: MOUNJARO, VRAYLAR, Rybelsus, Cologuard Collection Kit, REXULTI, FARXIGA, Auvelity, Ozempic.
Industry payments across AL — which companies pay providers there.
